000 01727 a2200529 4500
005 20250513231915.0
264 0 _c20010222
008 200102s 0 0 eng d
022 _a0250-7005
040 _aNLM
_beng
_cNLM
100 1 _aBellino, R
245 0 0 _aEpidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.
_h[electronic resource]
260 _bAnticancer research
_c
300 _a4825-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDisease Progression
650 0 4 _aDisease-Free Survival
650 0 4 _aEpirubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLymph Node Excision
650 0 4 _aLymphatic Metastasis
650 0 4 _aMastectomy, Modified Radical
650 0 4 _aMastectomy, Segmental
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasm Staging
650 0 4 _aPaclitaxel
_xadministration & dosage
700 1 _aCortese, P
700 1 _aDanese, S
700 1 _aDe Sanctis, C
700 1 _aDurando, A
700 1 _aGenta, F
700 1 _aGrio, R
700 1 _aGiardina, G
700 1 _aKatsaros, D
700 1 _aMassobrio, M
700 1 _aRichiardi, G
700 1 _aVicelli, R
773 0 _tAnticancer research
_gvol. 20
_gno. 6C
_gp. 4825-8
999 _c11143268
_d11143268